Amylyx Pharmaceuticals ENDO 2026 Poster: Characterizing the Burden of Post-Bariatric Hypoglycemia in the United States (5047b4)

Amylyx Pharmaceuticals Inc. published this content on June 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 14, 2026 at 17:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]